PG

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target by $10 to $157, 24x our FY24 (Jun.) EPS view of $6.55 (up $0.15; FY25 EPS down $0.36 to $6.86), in line with the one-year forward P/E average. F1Q EPS of $1.83 beat by $0.11 on revenue of $21.9B, in line with consensus. Pricing (+7.0%) and volume (-1.0%) were in line with F4Q, though mix came in lower by 100 bps, while tapering FX headwinds of 1% vs. 3% in F4Q offered some relief. Operating margin (+240 bps Y/Y) benefited from pricing, lower input costs, and productivity savings, partially offset by higher marketing costs and wage inflation. PG remains bullish on China, citing projected middle-income consumer growth. Near-term, we view PG as minimally exposed to private label vs. peers, as its portfolio […]

Procter & Gamble (NYSE:PG)  Fiscal Year 2024 Guidance P&G adjusted its guidance range for fiscal 2024 all-in sales growth to be in the range of two to four percent versus the prior year. Foreign exchange is now expected to be a headwind of approximately one to two percentage points to all-in sales growth. The Company maintained its outlook for organic sales growth in the range of four to five percent. P&G maintained its fiscal 2024 diluted net earnings per share growth in the range of six to nine percent versus fiscal 2023 EPS of $5.90. This outlook equates to a range of $6.25 to $6.43 per share. The Company highlighted that it is maintaining the EPS range despite an incremental $600 million dollars after tax of foreign exchange headwinds since its initial fiscal 2024 guidance in late July.

Procter & Gamble (NYSE:PG) Announces Fiscal Year 2024 First Quarter Results Net Sales +6%; Organic Sales +7% Diluted EPS and Core EPS $1.83, each +17% UPDATES ALL-IN SALES GROWTH OUTLOOK October 18, 2023– The Procter & Gamble Company (NYSE:PG) reported first quarter fiscal year 2024 net sales of $21.9 billion, an increase of six percent versus the prior year. Organic sales, which excludes the impacts of foreign exchange and acquisitions and divestitures, increased seven percent. Diluted net earnings per share were $1.83, an increase of 17% versus prior year. Operating cash flow was $4.9 billion, and net earnings were $4.6 billion for the quarter. Adjusted free cash flow productivity was 97%, which is calculated as operating cash flow excluding capital spending and certain other items, as a percentage of net earnings. The Company returned $3.8 billion of cash to shareowners via approximately $2.3 billion of dividend payments and $1.5 billion

Procter & Gamble (NYSE:PG) Still Sees FY24 EPS Growth in Range of Up 6%-9% Vs. FY23 EPS $5.90。

Procter & Gamble (NYSE:PG) Q1 Sales $21.9 Bln, up 6%; FactSet Consensus $21.6 Bln。

Procter & Gamble’s (PG) fundamental performance will stand out across its peer group as the manufacturer of consumer goods gears up to report its earnings this coming Wednesday, analysts at UBS said in a note issued Monday. Since outlining its initial guidance for fiscal 2024, which includes 3% to 4% in all-in sales growth and $6.25 to $6.43 in earnings per share, the Cincinnati, Ohio-based company has faced headwinds in the form of unfavorable foreign exchange rates, rising oil costs, and lower-than-expected recovery in China. Still, pressure from these headwinds is expected to be more than offset by underlying performance in both the US and Europe, analysts said. UBS’s price target on the company’s stock remains unchanged at $168 per share with a Buy rating.

Barclays analyst Lauren Lieberman maintains Procter & Gamble (NYSE:PG) with a Overweight and lowers the price target from $166 to $154.

Bernstein analyst Callum Elliott maintains Procter & Gamble (NYSE:PG) with a Market Perform and lowers the price target from $162 to $153.